A new study from researchers at the Hospital of the University of Pennsylvania reports that endoluminal (endoscopic) therapies, combining resection and ablation techniques, for patients with Barrett's ...

Endoluminal therapy combining endoscopic mucosal resection and ablation is successful long-term in patients with Barrett's esophagus (BE) and high-grade dysplasia (HGD) or intramucosal carcinoma, ...

Adenocarcinoma of the esophagus is currently characterized by a steep increase in incidence. Surveillance programs for patients with known Barrett's esophagus lead to an earlier detection of neoplasia ...

Barrett's esophagus (BE) is a precancerous condition with a known risk of progressing to cancer, especially when high-grade dysplasia (HGD, abnormal cells) is observed. A new study from researchers at ...

Please provide your email address to receive an email when new articles are posted on . Eradication and recurrence rates of dysplasia or neoplasia are similar in patients with Barrett’s esophagus and ...

Perelman School of Medicine conducted a study of endoluminal therapy, an endoscopy-based treatment, on patients with Barrett’s esophagus or in the early stages of cancer and found that neoplasia was ...

OAK BROOK, Ill. – February 12, 2013 – A new study from researchers at the Hospital of the University of Pennsylvania reports that endoluminal (endoscopic) therapies, combining resection and ablation ...

A new study reports that endoluminal (endoscopic) therapies, combining resection and ablation techniques, for patients with Barrett's esophagus and high-grade dysplasia or early mucosal cancer have a ...